These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 36178208)
21. KRAS G12C fragment screening renders new binding pockets. Mathieu M; Steier V; Fassy F; Delorme C; Papin D; Genet B; Duffieux F; Bertrand T; Delarbre L; Le-Borgne H; Parent A; Didier P; Marquette JP; Lowinski M; Houtmann J; Lamberton A; Debussche L; Alexey R Small GTPases; 2022 Jan; 13(1):225-238. PubMed ID: 34558391 [TBL] [Abstract][Full Text] [Related]
22. D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical Activities. Zhang J; Lim SM; Yu MR; Chen C; Wang J; Wang W; Rui H; Lu J; Lu S; Mok T; Chen ZJ; Cho BC Cancer Discov; 2024 Sep; 14(9):1675-1698. PubMed ID: 38717075 [TBL] [Abstract][Full Text] [Related]
23. HER2 mediates clinical resistance to the KRAS Ho CSL; Tüns AI; Schildhaus HU; Wiesweg M; Grüner BM; Hegedus B; Schuler M; Schramm A; Oeck S Eur J Cancer; 2021 Dec; 159():16-23. PubMed ID: 34715459 [TBL] [Abstract][Full Text] [Related]
24. A case of hepatoid adenocarcinoma of the lung harboring KRAS G12C responded favorably to sotorasib. Uruga H; Miyamoto A; Fujii T; Okuma T; Mitsumura T; Tamaoka M; Takazawa Y Pathol Int; 2024 Sep; 74(9):546-551. PubMed ID: 39016668 [TBL] [Abstract][Full Text] [Related]
25. Absorption, Distribution, Metabolism, and Excretion of [ Dahal UP; Rock BM; Rodgers J; Shen X; Wang Z; Wahlstrom JL Drug Metab Dispos; 2022 May; 50(5):600-612. PubMed ID: 35153196 [TBL] [Abstract][Full Text] [Related]
26. Asymmetric Synthesis of Axially Chiral Molecules via Organocatalytic Cycloaddition and Cyclization Reactions. Cai WY; Ding QN; Zhou L; Chen J Molecules; 2023 May; 28(11):. PubMed ID: 37298781 [TBL] [Abstract][Full Text] [Related]
27. Chiral Pd-Catalyzed Enantioselective Syntheses of Various N-C Axially Chiral Compounds and Their Synthetic Applications. Kitagawa O Acc Chem Res; 2021 Feb; 54(3):719-730. PubMed ID: 33481580 [TBL] [Abstract][Full Text] [Related]
28. Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy. Kirschner T; Müller MP; Rauh D J Med Chem; 2024 Apr; 67(8):6044-6051. PubMed ID: 38621359 [TBL] [Abstract][Full Text] [Related]
29. Organocatalytic Atroposelective Synthesis of Indole Derivatives Bearing Axial Chirality: Strategies and Applications. Zhang HH; Shi F Acc Chem Res; 2022 Sep; 55(18):2562-2580. PubMed ID: 36053083 [TBL] [Abstract][Full Text] [Related]
30. Sotorasib for Vascular Malformations Associated with Fraissenon A; Bayard C; Morin G; Benichi S; Hoguin C; Protic S; Zerbib L; Ladraa S; Firpion M; Blauwblomme T; Naggara O; Duruisseaux M; Delous M; Boitel C; Bringuier PP; Payen L; Legendre C; Kaltenbach S; Balducci E; Villarese P; Asnafi V; Bisdorff A; Guibaud L; Canaud G N Engl J Med; 2024 Jul; 391(4):334-342. PubMed ID: 39018528 [No Abstract] [Full Text] [Related]
31. The role of chromatographic and chiroptical spectroscopic techniques and methodologies in support of drug discovery for atropisomeric drug inhibitors of Bruton's tyrosine kinase. Dai J; Wang C; Traeger SC; Discenza L; Obermeier MT; Tymiak AA; Zhang Y J Chromatogr A; 2017 Mar; 1487():116-128. PubMed ID: 28131592 [TBL] [Abstract][Full Text] [Related]
32. Recent encounters with atropisomerism in drug discovery. Glunz PW Bioorg Med Chem Lett; 2018 Jan; 28(2):53-60. PubMed ID: 29223590 [TBL] [Abstract][Full Text] [Related]
33. Recent progress toward developing axial chirality bioactive compounds. Wang Z; Meng L; Liu X; Zhang L; Yu Z; Wu G Eur J Med Chem; 2022 Dec; 243():114700. PubMed ID: 36058089 [TBL] [Abstract][Full Text] [Related]
34. Catalytic Asymmetric Synthesis of Atropisomers Bearing Multiple Chiral Elements: An Emerging Field. Zhang HH; Li TZ; Liu SJ; Shi F Angew Chem Int Ed Engl; 2024 Jan; 63(3):e202311053. PubMed ID: 37917574 [TBL] [Abstract][Full Text] [Related]
35. High Resolution Ion Mobility Enables the Structural Characterization of Atropisomers of GDC-6036, a KRAS G12C Covalent Inhibitor. Varona M; Dobson DP; Napolitano JG; Thomas R; Ochoa JL; Russell DJ; Crittenden CM J Am Soc Mass Spectrom; 2024 Nov; 35(11):2586-2595. PubMed ID: 39051157 [TBL] [Abstract][Full Text] [Related]
36. Catalytic Asymmetric Synthesis of Atropisomers Featuring an Aza Axis. Feng J; Lu CJ; Liu RR Acc Chem Res; 2023 Sep; 56(18):2537-2554. PubMed ID: 37694726 [TBL] [Abstract][Full Text] [Related]
37. Construction of Non-Biaryl Atropisomeric Amide Scaffolds Bearing a C-N Axis via Enantioselective Catalysis. Xiao X; Chen B; Yao YP; Zhou HJ; Wang X; Wang NZ; Chen FE Molecules; 2022 Oct; 27(19):. PubMed ID: 36235120 [TBL] [Abstract][Full Text] [Related]
39. Analytical strategies for successful enantioselective separation of atropisomeric polybrominated biphenyls 132 and 149 in environmental samples. Götsch A; Mariussen E; von der Recke R; Herzke D; Berger U; Vetter W J Chromatogr A; 2005 Jan; 1063(1-2):193-9. PubMed ID: 15700471 [TBL] [Abstract][Full Text] [Related]
40. Combined Dynamic Kinetic Resolution and C-H Functionalization for Facile Synthesis of Non-Biaryl-Atropisomer-Type Axially Chiral Organosilanes. Li Z; Wang X; Cui YM; Ma JH; Fang LL; Han LL; Yang Q; Xu Z; Xu LW Chemistry; 2021 Mar; 27(13):4336-4340. PubMed ID: 33481303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]